Table 1.
Core criteria (both must be present) |
1. Slowly progressive or stepwise progressive, focal, asymmetric* limb weakness, that is, motor involvement in the motor nerve distribution of at least two nerves, for more than 1 month.† If symptoms and signs are present only in the distribution of one nerve only a possible diagnosis can be made (Table 4) |
2. No objective sensory abnormalities except for minor vibration sense abnormalities in the lower limbs‡ |
Supportive clinical criteria |
3. Predominant upper limb involvement§ |
4. Decreased or absent tendon reflexes in the affected limb¶ |
5. Absence of cranial nerve involvement** |
6. Cramps and fasciculations in the affected limb |
7. Response in terms of disability or muscle strength to immunomodulatory treatment |
Exclusion criteria |
8. Upper motor neuron signs |
9. Marked bulbar involvement |
10. Sensory impairment more marked than minor vibration loss in the lower limbs |
11. Diffuse symmetric weakness during the initial weeks |
Asymmetric = a difference of 1 MRC grade if strength is MRC >3 and 2 MRC grades if strength is MRC ⩽ 3.
Usually more than 6 months.
Sensory signs and symptoms may develop over the course of MMN.
At onset, predominantly lower limb involvement account for nearly 10% of the cases.
Slightly increased tendon reflexes, in particular in the affected arm, have been reported and do not exclude the diagnosis of MMN provided criterion 8 is met.
Twelfth nerve palsy has been reported.